Accéder au contenu
Merck
  • Separation and quantitation of the four stereoisomers of itraconazole in pharmaceutical formulations by electrokinetic chromatography.

Separation and quantitation of the four stereoisomers of itraconazole in pharmaceutical formulations by electrokinetic chromatography.

Electrophoresis (2006-01-18)
María Castro-Puyana, Antonio L Crego, M Luisa Marina
RÉSUMÉ

The four stereoisomers of itraconazole were resolved for the first time by EKC using a CD as chiral selector. A study on the enantiomeric separation ability of different neutral CDs was carried out. Heptakis-2,3,6-tri-O-methyl-beta-CD was shown to provide the highest values for the enantiomeric resolution. The influence of some experimental conditions, such as pH, chiral selector concentration, and temperature, on the enantiomeric separation was also studied. The use of a 100 mM phosphate buffer (pH 2.5), 30 mM in heptakis-2,3,6-tri-O-methyl-beta-CD together with an applied voltage of 30 kV and a temperature of 20 degrees C enabled the separation of the enantiomers of itraconazole with high resolutions (Rs > 3.0). Finally, the method was validated and successfully applied to the quantitation of itraconazole in three pharmaceutical formulations.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin, ≥90%
Sigma-Aldrich
Heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin, ≥98.0%